APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Diagnosis & Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HIV Diagnosis & Treatment Industry Growth and Trends Forecast to 2032

20 December 202589 pages

Choose your research edition.

Industry ResearchHIV Diagnosis & Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Diagnosis & Treatment Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HIV Diagnosis & Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Diagnosis & Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Diagnosis & Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global HIV Diagnosis & Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the HIV Diagnosis & Treatment market include Abbott Laboratories, Johnson & Johnson, GlaxoSmithKline, Gilead, F. Hoffmann-La Roche, Cipla, Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HIV Diagnosis & Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HIV Diagnosis & Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HIV Diagnosis & Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HIV Diagnosis & Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global HIV Diagnosis & Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HIV Diagnosis & Treatment Market by Company

Abbott Laboratories

Johnson & Johnson

GlaxoSmithKline

Gilead

F. Hoffmann-La Roche

Cipla

Bristol-Myers Squibb

Boehringer Ingelheim

HIV Diagnosis & Treatment Segment by Type

Saliva Tests

ELISA Test

Western Blot

Viral Load Test

Others

HIV Diagnosis & Treatment Segment by Application

Hospitals

Clinics

HIV Diagnosis & Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Diagnosis & Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Diagnosis & Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Diagnosis & Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of HIV Diagnosis & Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global HIV Diagnosis & Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global HIV Diagnosis & Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global HIV Diagnosis & Treatment Market Share by Region (2021-2026) Table 4. Global HIV Diagnosis & Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global HIV Diagnosis & Treatment Market Share by Region (2027-2032) Table 6. Global HIV Diagnosis & Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global HIV Diagnosis & Treatment Market Size Share by Type (2021-2026) Table 9. Global HIV Diagnosis & Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global HIV Diagnosis & Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America HIV Diagnosis & Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe HIV Diagnosis & Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America HIV Diagnosis & Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global HIV Diagnosis & Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global HIV Diagnosis & Treatment Market Size Share by Application (2021-2026) Table 24. Global HIV Diagnosis & Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global HIV Diagnosis & Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America HIV Diagnosis & Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe HIV Diagnosis & Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America HIV Diagnosis & Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. HIV Diagnosis & Treatment Industry Trends Table 37. HIV Diagnosis & Treatment Industry Drivers Table 38. HIV Diagnosis & Treatment Industry Opportunities and Challenges Table 39. HIV Diagnosis & Treatment Industry Restraints Table 40. Global HIV Diagnosis & Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global HIV Diagnosis & Treatment Revenue Market Share by Company (2021-2026) Table 42. Global HIV Diagnosis & Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global HIV Diagnosis & Treatment Key Company Headquarters & Area Served Table 44. Global HIV Diagnosis & Treatment Company, Product Type & Application Table 45. Global HIV Diagnosis & Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global HIV Diagnosis & Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Laboratories Company Information Table 49. Abbott Laboratories Business Overview Table 50. Abbott Laboratories HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio Table 52. Abbott Laboratories Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. GlaxoSmithKline Company Information Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio Table 62. GlaxoSmithKline Recent Development Table 63. Gilead Company Information Table 64. Gilead Business Overview Table 65. Gilead HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Gilead HIV Diagnosis & Treatment Product Portfolio Table 67. Gilead Recent Development Table 68. F. Hoffmann-La Roche Company Information Table 69. F. Hoffmann-La Roche Business Overview Table 70. F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio Table 72. F. Hoffmann-La Roche Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cipla HIV Diagnosis & Treatment Product Portfolio Table 77. Cipla Recent Development Table 78. Bristol-Myers Squibb Company Information Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio Table 82. Bristol-Myers Squibb Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim HIV Diagnosis & Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. North America HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America HIV Diagnosis & Treatment Market Size by Country (2021-2026) & (US$ Million) Table 90. North America HIV Diagnosis & Treatment Market Share by Country (2021-2026) Table 91. North America HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America HIV Diagnosis & Treatment Market Share Forecast by Country (2027-2032) Table 93. Europe HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe HIV Diagnosis & Treatment Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe HIV Diagnosis & Treatment Market Share by Country (2021-2026) Table 96. Europe HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe HIV Diagnosis & Treatment Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific HIV Diagnosis & Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific HIV Diagnosis & Treatment Market Share by Country (2021-2026) Table 101. Asia-Pacific HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific HIV Diagnosis & Treatment Market Share Forecast by Country (2027-2032) Table 103. Latin America HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America HIV Diagnosis & Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America HIV Diagnosis & Treatment Market Share by Country (2021-2026) Table 106. Latin America HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America HIV Diagnosis & Treatment Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa HIV Diagnosis & Treatment Market Share by Country (2021-2026) Table 111. Middle East & Africa HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa HIV Diagnosis & Treatment Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. HIV Diagnosis & Treatment Product Image Figure 3. Global HIV Diagnosis & Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global HIV Diagnosis & Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global HIV Diagnosis & Treatment Market Share by Region (2021-2032) Figure 7. North America HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Saliva Tests Image Figure 13. Global Saliva Tests Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. ELISA Test Image Figure 15. Global ELISA Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Western Blot Image Figure 17. Global Western Blot Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Viral Load Test Image Figure 19. Global Viral Load Test Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global HIV Diagnosis & Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global HIV Diagnosis & Treatment Market Share by Type 2025 VS 2032 Figure 24. North America HIV Diagnosis & Treatment Market Size Share by Type (2021-2032) Figure 25. Europe HIV Diagnosis & Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific HIV Diagnosis & Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America HIV Diagnosis & Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa HIV Diagnosis & Treatment Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global HIV Diagnosis & Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global HIV Diagnosis & Treatment Market Share by Application 2025 VS 2032 Figure 35. North America HIV Diagnosis & Treatment Market Size Share by Application (2021-2032) Figure 36. Europe HIV Diagnosis & Treatment Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific HIV Diagnosis & Treatment Market Size Share by Application (2021-2032) Figure 38. Latin America HIV Diagnosis & Treatment Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa HIV Diagnosis & Treatment Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 HIV Diagnosis & Treatment Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America HIV Diagnosis & Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America HIV Diagnosis & Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 45. Europe HIV Diagnosis & Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe HIV Diagnosis & Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 48. Asia-Pacific HIV Diagnosis & Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific HIV Diagnosis & Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 51. Latin America HIV Diagnosis & Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America HIV Diagnosis & Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 54. Middle East & Africa HIV Diagnosis & Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa HIV Diagnosis & Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Saliva Tests
  • ELISA Test
  • Western Blot
  • Viral Load Test
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Abbott Laboratories
  • Johnson & Johnson
  • GlaxoSmithKline
  • Gilead
  • F. Hoffmann-La Roche
  • Cipla
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global HIV Diagnosis & Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global HIV Diagnosis & Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global HIV Diagnosis & Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global HIV Diagnosis & Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions HIV Diagnosis & Treatment Market Size (2021-2032)
  8. 1.5.1 North America HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa HIV Diagnosis & Treatment Market Size Growth Rate (2021-2032)
2 HIV Diagnosis & Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Saliva Tests
  3. 2.1.2 ELISA Test
  4. 2.1.3 Western Blot
  5. 2.1.4 Viral Load Test
  6. 2.1.5 Others
  7. 2.2 Global HIV Diagnosis & Treatment Market Size by Type
  8. 2.2.1 Global HIV Diagnosis & Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global HIV Diagnosis & Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global HIV Diagnosis & Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global HIV Diagnosis & Treatment Market Size by Regions
  12. 2.3.1 North America HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Type (2021-2026)
3 HIV Diagnosis & Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.2 Global HIV Diagnosis & Treatment Market Size by Application
  5. 3.2.1 Global HIV Diagnosis & Treatment Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global HIV Diagnosis & Treatment Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global HIV Diagnosis & Treatment Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global HIV Diagnosis & Treatment Market Size by Regions
  9. 3.3.1 North America HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa HIV Diagnosis & Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 HIV Diagnosis & Treatment Industry Trends
  2. 4.2 HIV Diagnosis & Treatment Industry Drivers
  3. 4.3 HIV Diagnosis & Treatment Industry Opportunities and Challenges
  4. 4.4 HIV Diagnosis & Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by HIV Diagnosis & Treatment Revenue (2021-2026)
  2. 5.2 Global HIV Diagnosis & Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global HIV Diagnosis & Treatment Key Company Headquarters & Area Served
  4. 5.4 Global HIV Diagnosis & Treatment Company, Product Type & Application
  5. 5.5 Global HIV Diagnosis & Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global HIV Diagnosis & Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 HIV Diagnosis & Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 HIV Diagnosis & Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Gilead
  20. 6.4.1 Gilead Company Information
  21. 6.4.2 Gilead Business Overview
  22. 6.4.3 Gilead HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Gilead HIV Diagnosis & Treatment Product Portfolio
  24. 6.4.5 Gilead Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cipla HIV Diagnosis & Treatment Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Bristol-Myers Squibb
  38. 6.7.1 Bristol-Myers Squibb Company Information
  39. 6.7.2 Bristol-Myers Squibb Business Overview
  40. 6.7.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim HIV Diagnosis & Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  3. 7.3 North America HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  3. 10.3 South America HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa HIV Diagnosis & Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst